Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CNX | SON |
|---|---|---|
| Price | $32.24 | $48.22 |
| Change today | ▲ 2.35% | ▼ 1.07% |
| Market cap | $4.77B | $4.77B |
| Return, 3 months | -3.0% | -13.8% |
| Return, year to date | -12.3% | +13.8% |
| Return, 1 year | -3.2% | +17.9% |
| P/E (TTM) | 5.2 | 7.7 |
| P/B | 1.0 | 1.3 |
| P/E percentile vs own 5y | – | 31st |
| Dividend yield | – | 4.42% |
| Revenue growth (YoY, latest qtr) | -18.3% | +41.7% |
| Net profit growth (YoY) | -53.1% | +512.0% |
| Gross margin | 36.8% | 20.9% |
| Operating margin | 24.4% | 9.5% |
| Net margin | 45.9% | 13.3% |
| Return on equity | – | – |
| Analyst target vs. price | +10.4% | +23.6% |
| Analyst buy share | 0% | 33% |
| RSI (14) | 37 | 33 |
| 30-day volatility | 24.7% | 25.1% |
| Max drawdown, 1 year | -26.8% | -20.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.